Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Efficacy of Hemostatic Agents”

672 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 672 results

Large-scale testing (Phase 3)Study completedNCT01124981
What this trial is testing

Haemocomplettan® P During Elective Complex Cardiac Surgery

Who this might be right for
Fibrinogen Deficiency in Complex Cardiac Surgery
Isala 120
Early research (Phase 1)Study completedNCT00555100
What this trial is testing

Safety Study of Lenalidomide With and Without Dexamethasone in Japanese Subjects With Previously Treated Multiple Myeloma

Who this might be right for
Multiple Myeloma
Celgene 15
Not applicableNot Yet RecruitingNCT06720207
What this trial is testing

Efficacy of 68Ga-Pentixafor PET/MR in Detecting Non-Hodgkin Lymphoma and Multiple Myeloma Lesions

Who this might be right for
Non Hodgkin's LymphomaMultiple Myeloma (MM)
Shanghai East Hospital 30
Testing effectiveness (Phase 2)Study completedNCT00602706
What this trial is testing

Samarium Sm 153 Lexidronam Pentasodium and High-Dose Melphalan in Treating Patients With Multiple Myeloma Undergoing Stem Cell Transplant

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
Mayo Clinic 76
Early research (Phase 1)Study completedNCT05270928
What this trial is testing

Study to Evaluate the Safety, Tolerance, Pharmacokinetics and Preliminary Efficacy of IBI346#CIBI346Y001#

Who this might be right for
Relapsed/Refractory Multiple Myeloma
The First Affiliated Hospital of Soochow University 6
Large-scale testing (Phase 3)Study completedNCT00551928
What this trial is testing

Lenalidomide Melphalan and Prednisone Versus High Dose Melphalan in Newly Diagnosed Multiple Myeloma Patients

Who this might be right for
Multiple MyelomaNewly Diagnosed Patients
Fondazione EMN Italy Onlus 402
Not applicableNot Yet RecruitingNCT07015021
What this trial is testing

The Efficacy and Safety of the Combination Therapy of Daratumumab, Cabozantinib, Pomalidomide, and Dexamethasone (D-KPd) in the Treatment of High-risk First-time Relapsed or Primary Refractory MM Patients

Who this might be right for
Multiple MyelomaCarfilzomibDaratumumab+1 more
The First Affiliated Hospital of Soochow University 72
Early research (Phase 1)WithdrawnNCT00547404
What this trial is testing

Phase I Study for Safety and Efficacy of P276-00 in Subjects With Myeloma

Who this might be right for
Multiple Myeloma
Piramal Enterprises Limited 35
Not applicableLooking for participantsNCT06698887
What this trial is testing

Evaluate the Long-Term Safety of Idecabtagene Vicleucel Treatment in Adults With Newly Diagnosed Multiple Myeloma in Korea

Who this might be right for
Multiple Myeloma
Bristol-Myers Squibb 15
Testing effectiveness (Phase 2)WithdrawnNCT03221634
What this trial is testing

Efficacy and Safety Study of Pembrolizumab (MK-3475) in Combination With Daratumumab in Participants With Relapsed Refractory Multiple Myeloma (MK-3475-668/KEYNOTE-668)

Who this might be right for
Multiple Myeloma
Merck Sharp & Dohme LLC
Testing effectiveness (Phase 2)Looking for participantsNCT04976036
What this trial is testing

Efficacy of Nintedanib for Treatment of Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT) Patients

Who this might be right for
Telangiectasia, Hereditary Hemorrhagic
Dr. Romain Lazor 48
Early research (Phase 1)WithdrawnNCT05980507
What this trial is testing

An Open Label, Single-arm Clinical Study Evaluating the Safety and Efficacy of ICI201 Infusion in Relapsed/Refractory Multiple Myeloma

Who this might be right for
Relapsed/Refractory Multiple Myeloma
The First Affiliated Hospital of Soochow University
Testing effectiveness (Phase 2)Active Not RecruitingNCT05952037
What this trial is testing

Investigate Efficacy and Safety of BCL2 Inhibitor Sonrotoclax as Monotherapy and in Combination With Zanubrutinib in Adults With Waldenström Macroglobulinemia

Who this might be right for
Waldenstrom MacroglobulinemiaWaldenstrom's Macroglobulinemia RecurrentWaldenstrom's Macroglobulinemia Refractory
BeOne Medicines 114
Testing effectiveness (Phase 2)UnknownNCT02874326
What this trial is testing

Octreotide in Patients With GI Bleeding Due to Rendu-Osler-Weber

Who this might be right for
Hereditary Hemorrhagic TelangiectasiaGastrointestinal HemorrhageAnemia
Radboud University Medical Center 15
Testing effectiveness (Phase 2)Study completedNCT00908232
What this trial is testing

Treatment With Velcade (Bortezomib) Plus Dexamethasone (VD) or VD Plus Cyclophosphamide or VD Plus Lenalidomide in Patients With Multiple Myeloma Stabilized After 4 Cycles of VD

Who this might be right for
Multiple Myeloma
Janssen-Cilag International NV 163
Post-approval studies (Phase 4)Study completedNCT03934684
What this trial is testing

Study to Evaluate Safety Tolerability & Efficacy of Kyprolis (Carfilzomib) in Relapsed or Refractory Multiple Myeloma

Who this might be right for
Relapsed Refractory Multiple Myeloma
Amgen 101
Testing effectiveness (Phase 2)Study completedNCT00086216
What this trial is testing

Safety and Efficacy of Atiprimod for Patients With Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Callisto Pharmaceuticals 30
Not applicableStudy completedNCT04580563
What this trial is testing

Study Assessing Efficacy of Plasmatherapy in Septic Shock-induced Coagulopathy: Feasibility Study

Who this might be right for
Septic ShockCoagulopathyDisseminated Intravascular Coagulation
University Hospital, Strasbourg, France 60
Testing effectiveness (Phase 2)Looking for participantsNCT05099471
What this trial is testing

Efficacy of Venetoclax in Combination With Rituximab in Waldenström's Macroglobulinemia

Who this might be right for
Waldenstrom MacroglobulinemiaTreatment Naive
Christian Buske 80
Testing effectiveness (Phase 2)Looking for participantsNCT06132711
What this trial is testing

Safety and Efficacy of APRIL-BAFF-Bicephali CAR-T in Relapsed, Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Xuzhou Medical University 20
Load More Results